ROIV
Price
$20.22
Change
-$0.05 (-0.25%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
14.05B
87 days until earnings call
Intraday BUY SELL Signals
TVTX
Price
$34.69
Change
-$0.04 (-0.12%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
3.1B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ROIV vs TVTX

Header iconROIV vs TVTX Comparison
Open Charts ROIV vs TVTXBanner chart's image
Roivant Sciences
Price$20.22
Change-$0.05 (-0.25%)
Volume$158.89K
Capitalization14.05B
Travere Therapeutics
Price$34.69
Change-$0.04 (-0.12%)
Volume$99.26K
Capitalization3.1B
ROIV vs TVTX Comparison Chart in %
ROIV
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ROIV vs. TVTX commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Hold and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (ROIV: $20.20 vs. TVTX: $34.69)
Brand notoriety: ROIV and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 51% vs. TVTX: 82%
Market capitalization -- ROIV: $14.05B vs. TVTX: $3.1B
ROIV [@Biotechnology] is valued at $14.05B. TVTX’s [@Biotechnology] market capitalization is $3.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 1 green FA rating(s).

  • ROIV’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TVTX is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 2 TA indicator(s) are bullish while TVTX’s TA Score has 3 bullish TA indicator(s).

  • ROIV’s TA Score: 2 bullish, 6 bearish.
  • TVTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TVTX is a better buy in the short-term than ROIV.

Price Growth

ROIV (@Biotechnology) experienced а -0.44% price change this week, while TVTX (@Biotechnology) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

ROIV is expected to report earnings on Feb 16, 2026.

TVTX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($14B) has a higher market cap than TVTX($3.1B). TVTX YTD gains are higher at: 99.139 vs. ROIV (70.752). TVTX has higher annual earnings (EBITDA): -22.58M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. TVTX (255M). ROIV has less debt than TVTX: ROIV (99.7M) vs TVTX (330M). TVTX has higher revenues than ROIV: TVTX (436M) vs ROIV (23.2M).
ROIVTVTXROIV / TVTX
Capitalization14B3.1B451%
EBITDA-1.18B-22.58M5,206%
Gain YTD70.75299.13971%
P/E Ratio1.97N/A-
Revenue23.2M436M5%
Total Cash4.5B255M1,766%
Total Debt99.7M330M30%
FUNDAMENTALS RATINGS
TVTX: Fundamental Ratings
TVTX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ROIVTVTX
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ROIV
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIG36.020.42
+1.18%
ProShares Ultra Energy
SPAM31.710.36
+1.15%
Themes Cybersecurity ETF
RFI11.180.10
+0.90%
Cohen and Steers Total Return Realty Fund
YEAR50.660.04
+0.09%
AB Ultra Short Income ETF
FTBI20.880.01
+0.06%
First Trust Balanced Income ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.35%
IMVT - ROIV
54%
Loosely correlated
-0.88%
ACLX - ROIV
52%
Loosely correlated
+0.51%
RVMD - ROIV
52%
Loosely correlated
+1.40%
ARWR - ROIV
49%
Loosely correlated
+6.20%
KYMR - ROIV
49%
Loosely correlated
+2.44%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with ROIV. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-0.12%
ROIV - TVTX
40%
Loosely correlated
-0.35%
ARWR - TVTX
39%
Loosely correlated
+6.20%
XNCR - TVTX
38%
Loosely correlated
+1.77%
WVE - TVTX
38%
Loosely correlated
+4.37%
RCUS - TVTX
38%
Loosely correlated
+3.86%
More